Well again, I'm not sure I fully understand all the reservations you or others have, but I’d suggest that it's really a couple of things. We've talked about the paid loss ratio in the past, and we're happy to pick up that conversation anytime anyone wishes to. In addition to that, we've talked about the strength of our IBNR compared to total reserves, as well as the strength of our IBNR relative to case, and you can see that trend. And then in addition to that, I think on the last call or two, we talked about our initial IBNR relative to our earned premium, Rich, which we brought back to people's attention because I think, there were some question with the other metrics we were putting forth. Well, how is that impacted by the fact that the business is growing? So that's why we try to draw people's attention to the initial IBNR relative to earned, which should take into account growth. In addition to that, I think that there are a lot of folks that before they reach conclusions, they need to unpack our mix of business with greater granularity. And there are some people that have offered a view on the more recent years and how we've thought about those reserves without having a full appreciation for in some cases where we're using a claims made form as opposed to an incurrence form or amongst other mixes of business. So we look at our loss reserves, very regularly, every quarter, we look at it at a very granular level by operating business, by product line, and we look at the aggregate and we look at it in between the two. And from our perspective, ultimately we respect the fact that everyone is entitled to their opinion. At the same time, we are doing the best we can to try and help people understand but there is also a reality and it is going to be hard for us to prove it other than through the passage of time. I think the last point that I would raise, as it relates to the topic of reserves. I think the world oftentimes paints with a very broad brush. And when they see other market participants having to grapple with some challenging circumstances, they look at the product line particularly when it is casualty or liability exposure. And then they'll extrapolate and they'll say, well, this company over here had problems with this product line, so let's go out and look at who else would potentially have that exposure, and then they'll make this leap that, that is going to be an issue for everyone. And I think that, that can be a very slippery slope and would encourage people to invest the additional time and perhaps use a finer brush and recognizing that there is a greater distinction than perhaps I appreciate at base value.